Oppenheimer & Co’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-47,000
| Closed | -$230K | – | 1421 |
|
2022
Q3 | $230K | Sell |
47,000
-29,600
| -39% | -$145K | 0.01% | 1166 |
|
2022
Q2 | $317K | Sell |
76,600
-41,850
| -35% | -$173K | 0.01% | 1090 |
|
2022
Q1 | $688K | Hold |
118,450
| – | – | 0.01% | 888 |
|
2021
Q4 | $888K | Sell |
118,450
-36,850
| -24% | -$276K | 0.02% | 819 |
|
2021
Q3 | $1.4M | Sell |
155,300
-41,563
| -21% | -$374K | 0.03% | 620 |
|
2021
Q2 | $2.36M | Buy |
196,863
+130,300
| +196% | +$1.56M | 0.04% | 466 |
|
2021
Q1 | $834K | Buy |
+66,563
| New | +$834K | 0.02% | 767 |
|